MWM
BIIB icon

Moran Wealth Management’s Biogen BIIB Stock Holding History

Moran Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,592
Closed -$502K – 416
2024
Q3 		$502K Sell
2,592
-45
-2% -$9.41K 0.02% 375
2024
Q2 		$611K Buy
2,637
+377
+17% +$81.9K 0.02% 326
2024
Q1 		$487K Buy
2,260
+158
+8% +$37K 0.02% 325
2023
Q4 		$544K Buy
+2,102
New +$516K 0.02% 333

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Moran Wealth Management's BIIB Position: Q4 2024 in Review

Moran Wealth Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,592 shares — an estimated $502K sold.

Moran Wealth Management first reported a position in BIIB in Q4 2023 and held it in 4 quarters. The position peaked at $611K in Q2 2024. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Moran Wealth Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Moran Wealth Management sold 2,592 Biogen shares in Q4 2024, an estimated $502K.
  • Moran Wealth Management first reported a position in Biogen in Q4 2023 and held it in 4 quarters.
  • Moran Wealth Management's Biogen position peaked at $611K in Q2 2024.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Moran Wealth Management's 13F filing for Q4 2024, filed 7 Feb 2025.